Total and Differential White Blood Cell Counts, Cocaine, and Marijuana Use in Patients with Schizophrenia

Ryan L. Goetz, Brian J. Miller

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Schizophrenia is associated with blood inflammatory marker abnormalities. Illicit drug use, which is common in schizophrenia, may modulate inflammatory marker levels. We examined effects of marijuana and cocaine use on white blood cell (WBC) counts in acutely ill, hospitalized patients with schizophrenia using a within-subjects and between-groups design. Mean total and differential WBC counts were first compared in acutely ill patients with schizophrenia for hospitalizations with and without either marijuana (n = 18) or cocaine (n = 24) use. Mean total and differential WBC counts were then compared between patients with schizophrenia with either marijuana or cocaine use and patients with a negative urine drug screen (UDS; n = 43). Patients with schizophrenia had significantly higher total WBC, lymphocytes, and monocytes during hospitalizations with (vs. without) cocaine use. Patients with cocaine use also had significantly higher monocytes and eosinophils than those with a negative UDS. Our findings suggest that substance use, particularly of cocaine, may modulate inflammatory marker levels in acutely ill, hospitalized patients with schizophrenia.

Original languageEnglish (US)
JournalJournal of Nervous and Mental Disease
DOIs
Publication statusAccepted/In press - Jan 1 2019

    Fingerprint

Keywords

  • cocaine
  • inflammation
  • marijuana
  • Schizophrenia
  • white blood cells

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this